$7.05
Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion
Sagimet Biosciences Added to Russell Indexes
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
Overview
52-week range
$4.00
$11
41% of range
Avg surprise (last 3)
+27.7%
Avg reaction (last 2)
-2.4%
0% positive
Latest IV / EM
96%
EM ±22.0% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.33 | $-0.39 | +15.4% | +41.1% | -0.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.40 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.32 | $-0.52 | +38.5% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.56 | $-0.79 | +29.1% | — | -4.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.45 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.23 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.35 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-35.80 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.28 | -$0.32 | +12.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-12M | — | $-14M | $-12M | $-20M | — | $-17M | $-11M |
| Net income | $-11M | — | $-13M | $-10M | $-18M | — | $-15M | $-8M |
| EPS (diluted) | $-0.33 | — | $-0.40 | $-0.32 | $-0.56 | — | $-0.45 | $-0.25 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $37M | $35M | $32M | $42M | $65M | $76M | $77M | $96M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $108M | $116M | $119M | $127M | $146M | $153M | $157M | $167M |
| Total assets | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | $7M | $4M | $4M | $6M |
| Total equity | $102M | $111M | $119M | $130M | $139M | $156M | $171M | $183M |